Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Efstathiou

Showing results (181-190 of 273) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancerAyal A Aizer, Jonathan J Paly, Anthony L Zietman, et al.
World Journal of Urology|January 27, 2019
SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancerJeffrey J Leow, Jens Bedke, Karim Chamie, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Models of care and NCCN guideline adherence in very-low-risk prostate cancerAyal A Aizer, Jonathan J Paly, Anthony L Zietman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2018
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialJohn J Coen, Peixin Zhang, Philip J Saylor, et al.
European Urology|January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital ExperienceNicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
Cancer|February 26, 2013
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancerPhillip J Gray, Jonathan J Paly, Beow Y Yeap, et al.
European Urology|February 5, 2019
Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerJason A Efstathiou, Kent W Mouw, Ewan A Gibb, et al.
European Urology|May 15, 2018
Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al.
JCO Clinical Cancer Informatics|March 19, 2025
Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With RadiotherapyKeyur D Shah, Beow Y Yeap, Hoyeon Lee, et al.
Pageof 28

Showing results (181-190 of 273) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancerAyal A Aizer, Jonathan J Paly, Anthony L Zietman, et al.
World Journal of Urology|January 27, 2019
SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancerJeffrey J Leow, Jens Bedke, Karim Chamie, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Models of care and NCCN guideline adherence in very-low-risk prostate cancerAyal A Aizer, Jonathan J Paly, Anthony L Zietman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2018
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialJohn J Coen, Peixin Zhang, Philip J Saylor, et al.
European Urology|January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital ExperienceNicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
Cancer|February 26, 2013
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancerPhillip J Gray, Jonathan J Paly, Beow Y Yeap, et al.
European Urology|February 5, 2019
Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerJason A Efstathiou, Kent W Mouw, Ewan A Gibb, et al.
European Urology|May 15, 2018
Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al.
JCO Clinical Cancer Informatics|March 19, 2025
Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With RadiotherapyKeyur D Shah, Beow Y Yeap, Hoyeon Lee, et al.
Pageof 28